Chronic Obstructive Pulmonary Disease (COPD) Market. COPD market grows with rising disease prevalence, innovation in therapies, and increasing global healt ...

Wildfire smoke can have immediate and lasting effects on health, according to Dr. Sophia Meziani, an emergency medicine ...

The head of the Roman Catholic Church, Pope Francis, has died at the age of 88 years after battling a series of illnesses, ...

Bronchitis is a condition in which the airways in your lungs, called the Trachea and the Bronchi, get inflamed and fill with ...

New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as lunsekimig and itepekimab ...

With Chronic Breathing Issues on the Rise, AirPhysio Emerges as a Breakthrough Drug-Free Device Helping Millions Naturally ...

Long-distance caregivers can help manage a loved one’s finances, organize their medical appointments, coordinate with other ...

Sanofi today shared new progress from its mid- to late-stage respiratory pipeline, including preliminary phase 2 results for amlitelimab in adults with moderate-to-severe asthma.

Sanofi's respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD New phase 2 data for amlitelimab show efficacy in heterogeneous inflammatory asthma Lunsekimig ...

Paris, April 15, 2025. Sanofi today shared new progress from its mid- to late-stage respiratory pipeline, including preliminary phase 2 results for amlitelimab in adults with moderate-to-severe asthma ...

Chronic Obstructive Pulmonary Disease (COPD), which encompasses chronic bronchitis and emphysema, is a group of diseases that causes chronic airway inflammation and muscle constriction ...